Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) Research & Development: 2009-2024

Historic Research & Development for RedHill Biopharma (RDHL) over the last 16 years, with Dec 2024 value amounting to $1.6 million.

  • RedHill Biopharma's Research & Development fell 15.29% to $1.2 million in Q2 2023 from the same period last year, while for Jun 2023 it was $5.1 million, marking a year-over-year decrease of 68.71%. This contributed to the annual value of $1.6 million for FY2024, which is 54.99% down from last year.
  • As of FY2024, RedHill Biopharma's Research & Development stood at $1.6 million, which was down 54.99% from $3.5 million recorded in FY2023.
  • RedHill Biopharma's 5-year Research & Development high stood at $29.5 million for FY2021, and its period low was $1.6 million during FY2024.
  • For the 3-year period, RedHill Biopharma's Research & Development averaged around $4.1 million, with its median value being $3.5 million (2023).
  • As far as peak fluctuations go, RedHill Biopharma's Research & Development surged by 78.87% in 2021, and later slumped by 75.32% in 2022.
  • RedHill Biopharma's Research & Development (Yearly) stood at $16.5 million in 2020, then soared by 78.87% to $29.5 million in 2021, then plummeted by 75.32% to $7.3 million in 2022, then plummeted by 51.53% to $3.5 million in 2023, then slumped by 54.99% to $1.6 million in 2024.